Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
The DOI matches its Crossref record.
Abstract
The classifications of hepatocellular carcinoma (HCC) currently used are based on prognostic factors obtained from studies performed years ago when most tumors were diagnosed at advanced stages and the survival rates were substantially poor. Recent investigations have reviewed the survival of early tumors properly selected to receive radical therapies and the natural outcome of nonsurgical HCC patients. These data enable a new staging system to be proposed, the Barcelona Clinic Liver Cancer (BCLC) staging classification, that comprises four stages that select the best candidates for the best therapies currently available. Early stage (A) includes patients with asymptomatic early tumors suitable for radical therapies--resection, transplantation or percutaneous treatments. Intermediate stage (B) comprises patients with asymptomatic multinodular HCC. Advanced stage (C) includes patients with symptomatic tumors and/or an invasive tumoral pattern (vascular invasion/extrahepatic spread). Stage B and C patients may receive palliative treatments/new agents in the setting of phase II investigations or randomized controlled trials. End-stage disease (D) contain patients with extremely grim prognosis (Okuda stage III or PST 3-4) that should merely receive symptomatic treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The management of patients with HCC has improved markedly since the first BCLC classification was proposed in 1999143.”
From Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024) · cites this paper as [143]
Citations
Cites
Still being checked.
Cited by
Items 301–400 of 1,005
Pompili, M., Francica, G., Ponziani, F. R., Iezzi, R., & Avolio, A. W. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i43.7515 · Cited by 135
Zhang, X., Gao, Y., Chen, Z., Chen, M., Li, L., Wen, T., Xu, L., Wang, K., Chai, Z., Guo, W., et al. (2018) · Hepatology · doi:10.1002/hep.30490 · Cited by 135
Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial
Lin, C., Hsu, C., Hsu, C., Hsu, W.-L., Cheng, A., & Yang, C.-H. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-9004-9 · Cited by 135
Haradome, H., Grazioli, L., Tinti, R., Morone, M., Motosugi, U., Sano, K., Ichikawa, T., Kwee, T. C., & Colagrande, S. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22588 · Cited by 134
Dai, C.-X., Gao, Q., Qiu, S.-J., Ju, M.-J., Cai, M.-Y., Xu, Y.-F., Zhou, J., Zhang, B.-H., & Fan, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-418 · Cited by 133
Kim, K. M., Kim, J., Park, I. S., Ko, G., Yoon, H., Sung, K., Lim, Y., Lee, H. C., Chung, Y. H., Lee, Y. S., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05728.x · Cited by 133
Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
Inchingolo, R., Posa, A., Mariappan, M., & Spiliopoulos, S. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i32.4614 · Cited by 133
Practical utility of liver segmentation methods in clinical surgeries and interventions
Ansari, M. Y., Abdalla, A., Yaqoob, M., Ansari, M. I., Malluhi, B., Mohanty, S., Mishra, S., Singh, S. S., Abinahed, J. A., Al-Ansari, A. A., et al. (2022) · BMC Medical Imaging · doi:10.1186/s12880-022-00825-2 · Cited by 133
Cho, C. S., Gönen, M., Shia, J., Kattan, M. W., Klimstra, D. S., Jarnagin, W. R., D'Angelica, M. I., Blumgart, L. H., & DeMatteo, R. P. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.07.031 · Cited by 133
Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers
Toyoda, H., Kumada, T., Osaki, Y., Oka, H., Urano, F., Kudo, M., & Matsunaga, T. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.021 · Cited by 132
Diagnostik und Therapie des hepatozellulären Karzinoms
Greten, T. F., Malek, N. P., Schmidt, S., Arends, J., Bartenstein, P., Bechstein, W. O., Bernatik, T., Bitzer, M., Chavan, A., Dollinger, M. M., et al. (2013) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0033-1355841 · Cited by 131
Raoul, J., Bruix, J., Greten, T. F., Sherman, M., Mazzaferro, V., Hilgard, P. A., Scherübl, H., Scheulen, M. E., Germanidis, G. S., Dominguez, S., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.009 · Cited by 131
Self-citationTrevisani, F., Santi, V., Gramenzi, A., Di Nolfo, M. A., Poggio, P. D., Benvegnù, L., Rapaccini, G., Farinati, F., Zoli, M., Borzio, F., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01395.x · Cited by 109
Hao, K., Luk, J. M., Lee, N. P. Y., Mao, M., Zhang, C., Ferguson, M. D., Lamb, J. R., Dai, H. A., Ng, I. O., Sham, P. C., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-389 · Cited by 130
Guglielmi, A., Ruzzenente, A., Pachera, S., Valdegamberi, A., Sandri, M. F., D’Onofrio, M., & Iacono, C. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01604.x · Cited by 130
Hepatocellular Carcinoma in HIV-Infected Patients: Check Early, Treat Hard
Berretta, M., Garlassi, E., Cacopardo, B. S., Cappellani, A., Guaraldi, G., Cocchi, S., Paoli, P. D., Lleshi, A., Izzi, I. M., Torresin, A., et al. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0400 · Cited by 130
The Diagnosis and Treatment of Hepatocellular Carcinoma
Malek, N. P., Schmidt, S., Huber, P., Manns, M. P., & Greten, T. F. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0101 · Cited by 130
da Rocha, E. C. V., D’Amico, É. A., Caldwell, S. H., da Rocha, T. R. F., Silva, C. S. S. S. E., Bomfim, V. D. S., Felga, G. E. G., Barbosa, W. F., Kassab, F., Polli, D. A., et al. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.04.019 · Cited by 129
Dietrich, C., Lorentzen, T., Appelbaum, L., Buscarini, E., Cantisani, V., Correas, J., Cui, X., D’Onofrio, M., Gilja, O., Hocke, M., et al. (2016) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/s-0035-1553965 · Cited by 123
Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria
Gaba, R. C., Lewandowski, R. J., Hickey, R., Baerlocher, M. O., Cohen, E. I., Dariushnia, S. R., d’Othée, B. J., Padia, S. A., Salem, R., Wang, D. S., et al. (2016) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2015.12.752 · Cited by 128
Zhang, X., Wang, Z., Tang, W., Wang, X., Liu, R., Bao, H., Chen, X., Wei, Y., Wu, S., Bao, H., et al. (2021) · Hepatology · doi:10.1002/hep.32308 · Cited by 127
Percutaneous ablation of hepatocellular carcinoma: State-of-the-art
Lencioni, R. A., Cioni, D., Crocetti, L., & Bartolozzi, C. (2004) · Liver Transplantation · doi:10.1002/lt.20043 · Cited by 127
AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement
Henderson, J. M., Sherman, M., Tavill, A. S., Abecassis, M. M., Chejfec, G., & Gramlich, T. L. (2003) · HPB · doi:10.1080/13651820310015833 · Cited by 127
Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma
Yeo, W., Mo, F. K. F., Koh, J., Chan, A. T. �., Leung, T., Hui, P., Chan, S. L., Tang, A., Lee, J. J., Mok, T. S. K., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl065 · Cited by 127
Hucke, F., Sieghart, W., Pinter, M., Graziadei, I. W., Vogel, W., Müller, C., Heinzl, H., Waneck, F., Trauner, M., & Peck‐Radosavljevic, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.022 · Cited by 126
Müller, L., Hähn, F., Mähringer‐Kunz, A., Stoehr, F., Gairing, S. J., Michel, M. S., Foerster, F., Weinmann, A., Galle, P. R., Mittler, J., et al. (2021) · Cancers · doi:10.3390/cancers13195018 · Cited by 126
Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis
Nishikawa, H., & Osaki, Y. (2015) · Mediators of Inflammation · doi:10.1155/2015/872152 · Cited by 125
Becker, G., Allgaier, H., Olschewski, M., Zähringer, A., & Blum, H. E. (2006) · Hepatology · doi:10.1002/hep.21468 · Cited by 125
Koda, M., Murawaki, Y., Hirooka, Y., Kitamoto, M., Ono, M., Sakaeda, H., Joko, K., Sato, S., Tamaki, K., Yamasaki, T., et al. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01025.x · Cited by 125
Lu, S., Wang, J., Su, C., Wang, T.-E., Dai, C., Chen, C., Chen, R., Yang, S.-S., Hung, C., Huang, S.-F., et al. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.09.007 · Cited by 124
Ng, H. H. M., Lee, R. Y., Goh, S., Tay, I. S. Y., Lim, X., Lee, B., Chew, V., Li, H., Tan, B., Lim, S., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000987 · Cited by 116
Yoo, D., Kim, K. M., Jin, Y., Shim, J. H., Ko, G., Yoon, H., Sung, K., Lee, J., Kang, Y., Lim, Y., et al. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06341.x · Cited by 124
Targeted therapy for hepatocellular carcinoma
Spangenberg, H. C., Thimme, R., & Blum, H. E. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.86 · Cited by 125
Zhong, C., Guo, R., Li, J. Q., Shi, M., Wei, W., Chen, M.-S., & Zhang, Y.-Q. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0588-2 · Cited by 124
Okamura, Y., Ashida, R., Ito, T., Sugiura, T., Mori, K. P., & Uesaka, K. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-2982-z · Cited by 123
Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides
Khan, A. R., Wei, X., & Xu, X. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s318070 · Cited by 124
Liver Resection Improves the Survival of Patients with Multiple Hepatocellular Carcinomas
Ho, M., Huang, G., Tsang, Y.-M., Lee, P., Chen, D., Sheu, J., & Chen, C. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0282-7 · Cited by 123
Pegylated arginine deiminase: a novel anticancer enzyme agent
Feun, L., & Savaraj, N. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.815 · Cited by 118
Molmenti, E. P., & Klintmalm, G. B. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.34879 · Cited by 123
Jung, E. S., Kim, J. H., Yoon, E. L., Lee, H. J., Lee, S. J., Suh, S. J., Lee, B. J., Seo, Y. S., Yim, H. J., Seo, T.-S., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.039 · Cited by 122
Kinoshita, A., Onoda, H., Imai, N., Iwaku, A., Oishi, M., Tanaka, K., Fushiya, N., Koike, K., Nishino, H., Matsushima, M., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-52 · Cited by 122
Xu, L., Peng, Z., Chen, M.-S., Shi, M., Zhang, Y., Guo, R., Lin, X.-J., & Lau, W. Y. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.034 · Cited by 121
Fang, A., Chen, P., Wang, X., Liu, Z.-Y., Zhang, D., Luo, Y., Liao, G., Long, J., Zhong, R., Zhou, Z., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31991 · Cited by 122
CIRSE Standards of Practice on Hepatic Transarterial Chemoembolisation
Lucatelli, P., Burrel, M., Guiu, B., de Rubeis, G., van Delden, O., & Helmberger, T. (2021) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-021-02968-1 · Cited by 101
Cammà, C., Marco, V. D., Orlando, A., Sandonato, L., Casaril, A., PARISI, P., Alizzi, S., Sciarrino, E., Virdone, R., Pardo, S., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.042 · Cited by 120
Silva, J. P., Berger, N. G., Tsai, S., Christians, K. K., Clarke, C. N., Mogal, H., White, S. B., Rilling, W. S., & Gamblin, T. C. (2017) · HPB · doi:10.1016/j.hpb.2017.04.016 · Cited by 119
Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score
Hollebecque, A., Cattan, S., Romano, O., Sergent, G., Mourad, A., Louvet, A., Dharancy, S., Boleslawski, E., Truant, S., Pruvot, F., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04860.x · Cited by 119
Hepatocellular carcinoma: Epidemiology and clinical aspects
Mazzanti, R., Gramantieri, L., & Bolondi, L. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.008 · Cited by 119
Cho, Y. K., Chung, J. W., Kim, J. K., Ahn, Y. S., Kim, M. Y., Park, Y. O., Kim, W., & Byun, J. H. (2007) · Cancer · doi:10.1002/cncr.23185 · Cited by 119
Hussain, S. A., Ferry, D., El‐Gazzaz, G., Mirza, D. F., James, N. D., McMaster, P., & Kerr, D. (2001) · Annals of Oncology · doi:10.1023/a:1008370324827 · Cited by 119
Rim, C. H., Kim, C. Y., Yang, D. S., & Yoon, W. S. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.11.013 · Cited by 117
Child–Pugh Classification: Time to Abandon?
Kok, B., & Abraldeṣ, J. G. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1676805 · Cited by 118
The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinoma
D’Avola, D., Granito, A., de la Torre‐Aláez, M., & Piscaglia, F. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.013 · Cited by 118
Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study
Ohri, N., Dawson, L. A., Krishnan, S., Seong, J., Cheng, J. C., Sarin, S. K., Kinkhabwala, M. M., Ahmed, M. M., Vikram, B., Coleman, C. N., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw133 · Cited by 117
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
Weinmann, A., Alt, Y., Koch, S., Nelles, C., Düber, C., Lang, H., Otto, G., Zimmermann, T., Marquardt, J. U., Galle, P. R., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1197-x · Cited by 111
Intermediate hepatocellular carcinoma: current treatments and future perspectives
Dufour, J., Bargellini, I., Maria, N. D., SIMONE, P. D., Goulis, I., & Marinho, R. T. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt054 · Cited by 115
Liver surgery in cirrhosis and portal hypertension
Hackl, C., Schlitt, H. J., Renner, P., & Lang, S. A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i9.2725 · Cited by 115
Kim, G.-A., Shim, J. H., Kim, M.-J., Kim, S., Won, H., Shin, Y. M., Kim, P. N., Kim, K.-H., Lee, S.-G., & Lee, H. C. (2015) · British journal of surgery · doi:10.1002/bjs.9960 · Cited by 115
Treatment Options in Hepatocellular Carcinoma Today
Livraghi, T., Mäkisalo, H., & Line, P. (2011) · Scandinavian Journal of Surgery · doi:10.1177/145749691110000105 · Cited by 112
Kao, W., Su, C., Chiou, Y., Chiu, N., Liu, C., Fang, K., Huo, T., Huang, Y., Chang, C., Hou, M., et al. (2017) · Radiology · doi:10.1148/radiol.2017162382 · Cited by 112
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis
Bengtsson, B., Stål, P., Wahlin, S., Björkström, N. K., & Hagström, H. (2019) · Liver International · doi:10.1111/liv.14087 · Cited by 97
Koo, J. E., Kim, J. H., Lim, Y., Park, S. J., Won, H. J., Sung, K., & Suh, D. J. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1730 · Cited by 111
A review of hepatocellular carcinoma (HCC) staging systems.
Subramaniam, S., Kelley, R. K., & Venook, A. P. (2013) · PubMed · doi:10.3978/j.issn.2304-3865.2013.07.05 · Cited by 111
Chong, N., Schoenberger, H., Yekkaluri, S., Fetzer, D. T., Rich, N. E., Yokoo, T., Gopal, P., Manwaring, C., Quirk, L., & Singal, A. G. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16779 · Cited by 104
Conditional Survival after Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic Patients
Cucchetti, A., Piscaglia, F., Cescon, M., Ercolani, G., Terzi, E., Bolondi, L., Zanello, M., & Pinna, A. D. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2663 · Cited by 111
Serenari, M., Han, K., Ravaioli, F., Kim, S. U., Cucchetti, A., Han, D. H., Odaldi, F., Ravaioli, M., Festi, D., Pinna, A. D., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.032 · Cited by 110
Advanced hepatocellular carcinoma. Review of targeted molecular drugs
Rogério, C. P. A., Daniele, A., Guz, B., Carla, M., Monica, V., Harriz, M., Deborah, T., Mario, K., Gampel, O., & Poletti, P. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31582-0 · Cited by 110
Updates in the management of hepatocellular carcinoma.
Wong, R. J., & Frenette, C. T. (2011) · PubMed · Cited by 110
Diagnosis, staging and treatment of hepatocellular carcinoma
França, A. V. C., Elías, J., Lima, B. L. G., Martinelli, A. L. C., & Carrilho, F. J. (2004) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2004001100015 · Cited by 110
Yau, T. C. C., Yao, T., Chan, P., Wong, H., Pang, R. W. C., Fan, S. T., & Poon, R. T. P. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0105 · Cited by 109
Model to estimate survival in ambulatory patients with hepatocellular carcinoma
Yang, J. D., Kim, W. R., Park, K. W., Chaiteerakij, R., Kim, B., Sanderson, S. O., Larson, J. J., Pedersen, R. A., Therneau, T. M., Gores, G. J., et al. (2012) · Hepatology · doi:10.1002/hep.25680 · Cited by 110
The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States
Lee, Y., Wang, J. J., Luu, M., Noureddin, M., Kosari, K., Agopian, V. G., Rich, N. E., Lu, S. C.-L., Tseng, H., Nissen, N. N., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab079 · Cited by 108
Qi, L., Bai, T., Chen, Z.-S., Wu, F., Chen, Y., Xiang, B. D., Peng, T., Han, Z., & Li, L. (2014) · Liver International · doi:10.1111/liv.12460 · Cited by 109
Kappadath, S. C., Mikell, J. K., Balagopal, A., Baladandayuthapani, V., Kaseb, A. O., & Mahvash, A. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.05.062 · Cited by 107
Sotiropoulos, G. C., Malagó, M., Molmenti, E. P., Paul, A., Nadalin, S., Brokalaki, E. I., hl, H. K., Dirsch, O., Lang, H., & Broelsch, C. E. (2005) · Transplantation · doi:10.1097/01.tp.0000152801.82734.74 · Cited by 107
Kudo, M. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06207.x · Cited by 106
Liver tumor ablation: Percutaneous and open approaches
Padma, S., Martinie, J. B., & Iannitti, D. A. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21364 · Cited by 105
Current Trends and Recent Advances in Diagnosis, Therapy, and Prevention of Hepatocellular Carcinoma
Wang, C., Wey, K.-C., Mo, L.-R., Chang, K.-K., Lin, R., & Kuo, J.-J. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.9.3595 · Cited by 105
Yao, L., Chen, Z., Feng, Z., Diao, Y., Li, C., Sun, H.-Y., Zhong, J., Chen, T., Gu, W.-M., Zhou, Y.-H., et al. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-11454-y · Cited by 105
Hepatocellular Carcinoma: A Comprehensive Review
Amin, N. A., Anwar, J., Sulaiman, A. A., Naumova, N., & Anwar, N. (2025) · Diseases · doi:10.3390/diseases13070207 · Cited by 108
Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey
Fukami, Y., Kaneoka, Y., Maeda, A., Kumada, T., Tanaka, J., Akita, T., Kubo, S., Izumi, N., Kadoya, M., Sakamoto, M., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003192 · Cited by 105
Reiss, K. A., Yu, S., Mamtani, R., Mehta, R. L., D’Addeo, K., Wileyto, E. P., Taddei, T. H., & Kaplan, D. E. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.8245 · Cited by 104
Management of people with early- or very early-stage hepatocellular carcinoma
Majumdar, A., Roccarina, D., Thorburn, D., Davidson, B. R., Tsochatzis, E. A., & Gurusamy, K. S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011650.pub2 · Cited by 105
Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma
Rich, N. E., Murphy, C. C., Yopp, A. C., Tiro, J. A., Marrero, J. A., & Singal, A. G. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15917 · Cited by 107
Federico, A. D., Rizzo, A., Carloni, R., Giglio, A. D., Bruno, R., Ricci, D., & Brandi, G. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2009455 · Cited by 105
Trevisani, F., Vitale, A., Kudo, M., Kulik, L., Park, J., Pinato, D. J., & Cillo, U. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.010 · Cited by 105
Weinmann, A., Koch, S., Niederle, I. M., Schulze‐Bergkamen, H., König, J., Hoppe‐Lotichius, M., Hansen, T., Pitton, M. B., Düber, C., Otto, G., et al. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182a8a793 · Cited by 104
Molecular approaches to treatment of hepatocellular carcinoma
Lachenmayer, A., Alsinet, C., Chang, C., & Llovet, J. M. (2010) · Digestive and Liver Disease · doi:10.1016/s1590-8658(10)60515-4 · Cited by 104
Self-citationLoco-regional treatment of HCC: current status
Crocetti, L., Bargellini, I., & Cioni, R. (2017) · Clinical Radiology · doi:10.1016/j.crad.2017.01.013 · Cited by 105
Treatment of Hepatocellular Carcinoma
Díaz‐González, Á., Reig, M., & Bruix, J. (2016) · Digestive Diseases · doi:10.1159/000445275 · Cited by 104
Self-citationEarly diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
Amr, K. S., Atia, H. A., Elbnhawy, R. A. E., & Ezzat, W. M. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.10.003 · Cited by 103
Cho, Y., Kim, B. H., & Park, J. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0099 · Cited by 103
Niu, Z.-J., Ma, Y.-L., Kang, P., Ou, S., Meng, Z.-B., Li, Z.-K., Qi, F., & Zhao, C. (2011) · Medical Oncology · doi:10.1007/s12032-011-0145-0 · Cited by 103
Hyeon, J., Ahn, S., Lee, J. J., Song, D. H., & Park, C.-K. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2609-x · Cited by 103
Truty, M. J., & Vauthey, J. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0976-5 · Cited by 103
Ng, C. K. Y., Costanzo, G. G. D., Tosti, N., Paradiso, V., Coto‐Llerena, M., Roscigno, G., Perrina, V., Quintavalle, C., Boldanova, T., Wieland, S. F., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy083 · Cited by 102
Mulé, S., Thiéfin, G., Costentin, C. E., Durot, C., Rahmouni, A., Luciani, A., & Hoeffel, C. C. (2018) · Radiology · doi:10.1148/radiol.2018171320 · Cited by 102
Toni, E. N. D., Schlesinger‐Raab, A., Fuchs, M., Schepp, W., Ehmer, U., Geisler, F., Ricke, J., Paprottka, P. M., Friess, H., Werner, J., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-318193 · Cited by 102
Ueshima, K., Kudo, M., Takita, M., Nagai, T., Tatsumi, C., 上田, 泰., Kitai, S., Ishikawa, E., Yada, N., Inoue, T., et al. (2010) · Oncology · doi:10.1159/000315244 · Cited by 102
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?
Lupo, L., Panzera, P., Giannelli, G., Memeo, M., Gentile, A., & Memeo, V. (2007) · HPB · doi:10.1080/13651820701713758 · Cited by 102
Metadata
- Authors
- Llovet, J., Brú, C., & Bruix, J.
- Affiliations
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 1999
- Volume
- 19
- Issue
- 03
- Pages
- 329-338
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2147172608
- Cited by
- 3,805
- References
- 0
- Citations by year
- 2026: 70 · 2025: 117 · 2024: 162 · 2023: 211 · 2022: 269 · 2021: 280 · 2020: 279 · 2019: 215 · 2018: 206 · 2017: 218 · 2016: 216 · 2015: 220 · 2014: 219 · 2013: 163 · 2012: 154
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- hepatocellular carcinoma, prognosis, tumor staging, radical treatment, liver transplantation, hepatectomy, percutaneous treatment, vascular invasion, extrahepatic spread, palliative care, Okuda staging
- MeSH terms
- Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Prognosis, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.